Ignite Creation Date:
2025-12-24 @ 9:07 PM
Ignite Modification Date:
2025-12-25 @ 6:58 PM
Study NCT ID:
NCT02797704
Status:
TERMINATED
Last Update Posted:
2019-09-16
First Post:
2016-05-24
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Subconjunctival Aflibercept (EYLEA®) for the Treatment of Corneal Neovascularization
Sponsor:
Rabin Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-03-02
Start Date Type:
ACTUAL
Primary Completion Date:
2019-09-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-09-10
Completion Date Type:
ACTUAL
First Submit Date:
2016-05-24
First Submit QC Date:
None
Study First Post Date:
2016-06-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-09-12
Last Update Post Date:
2019-09-16
Last Update Post Date Type:
ACTUAL